TAK

#7025
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
18.7400
+1.22%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
18.7100
18.7600
Годовой диапазон
12.9900
18.8200
Дневное изменение
+1.22%
Месячное изменение
+12.62%
6-месячное изменение
+32.11%
Годовое изменение
+32.11%
Предыдущее закрытие
18.5150
Open
18.7250
Bid
Ask
Low
18.7100
High
18.7600
Объем
504
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 47 K
  • Founded N/A
  • CEO Christophe Weber
  • Website www.takeda.com
  • Headquarter Japan
  • FIGI BBG000LF8708
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

Новости